Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland.
IgG/IgM seroprevalence
SARS-CoV-2
general population
representative sample
risk factors
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
19 03 2021
19 03 2021
Historique:
received:
15
02
2021
revised:
11
03
2021
accepted:
16
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
10
4
2021
Statut:
epublish
Résumé
Lack of knowledge around seroprevalence levels of COVID-19 in Poland was the reason for the implementation of a seroepidemiological study in the Katowice Region (2,100,000 inhabitants). In October-November 2020, a questionnaire examination and measurement of anti-SARS-CoV-2 IgG and IgM antibodies were performed in a random sample of the general population (
Identifiants
pubmed: 33808716
pii: ijerph18063188
doi: 10.3390/ijerph18063188
pmc: PMC8003539
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin M
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agencja Badań Medycznych - Polska (Medical Research Agency - Poland)
ID : 2020/ABM/COVID19/0044
Références
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Am J Infect Control. 2021 Feb 22;:
pubmed: 33631305
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
PLoS One. 2021 Feb 17;16(2):e0245914
pubmed: 33596236
Int J Environ Res Public Health. 2020 Oct 27;17(21):
pubmed: 33121070
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Nat Commun. 2020 Sep 9;11(1):4507
pubmed: 32908126
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Curr Allergy Asthma Rep. 2020 Aug 3;20(10):61
pubmed: 32748211
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
Clin Microbiol Infect. 2021 Mar;27(3):331-340
pubmed: 33228974
Front Immunol. 2020 Aug 28;11:2147
pubmed: 32983176
mSphere. 2020 Oct 7;5(5):
pubmed: 33028689
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Nat Med. 2020 Aug;26(8):1193-1195
pubmed: 32504052
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32350047
BMJ. 2020 Sep 3;370:m3364
pubmed: 32883673
J Med Virol. 2021 Jan;93(1):64-65
pubmed: 32497290
Int J Infect Dis. 2020 Dec;101:314-322
pubmed: 33045429